Great post mate. I think after seeing the stability in the lower dosages, clues around potential efficacy on the higher dose cohorts are definitely what to watch for short term. May be a good time to get in early too as I think it's unlikely for the wider market to look between the lines like this on a phase 1 trial.
CHM Price at posting:
15.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)